Literature DB >> 25888814

Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons.

Susanne P Pallo1, Gail V W Johnson2.   

Abstract

Alzheimer's disease (AD) is defined by presence of two pathological hallmarks, the intraneuronal neurofibrillary tangle (NFT) formed by abnormally processed tau, and the extracellular amyloid plaques formed primarily by the amyloid beta peptide (Aβ). In AD it is likely that these two proteins act in concert to impair neuronal function, and there is evidence to suggest that one of the key targets on which they converge is the mitochondria. For example, overexpression of a pathologic form of tau in rat primary cortical neurons exacerbates Aβ-induced mitochondrial membrane potential (ΔΨm) loss due to impairment of the calcium (Ca(2+)) buffering capability of mitochondria. However the role of physiological levels of tau in mediating Aβ-induced mitochondrial dysfunction was not examined. Therefore in this present study we used primary neurons from wild type (WT) and tau knockout (tau(-/-)) mice to investigate whether endogenous tau facilitates Aβ-induced ΔΨm loss and alterations in cytosolic calcium (Ca(2+)cyt). Knocking out tau significantly protected mouse primary cortical neurons from loss of ΔΨm caused by low concentrations of Aβ42, which supports our previous findings. However, the absence of tau resulted in significantly greater increases in Ca(2+)cyt in response to Aβ treatment when compared to those observed in WT mouse primary cortical neurons. This unexpected outcome may be explained by findings that suggest tau(-/-) neurons display certain phenotypic abnormalities associated with alterations in Ca(2+)cyt. Overall, data indicate that tau facilitates Aβ-induced mitochondrial dysfunction and this effect is independent of Aβ-induced alterations in Ca(2+)cyt.(1).
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid beta; Calcium dyshomeostasis; Mitochondrial dysfunction; Tau

Mesh:

Substances:

Year:  2015        PMID: 25888814      PMCID: PMC4442715          DOI: 10.1016/j.neulet.2015.04.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  38 in total

1.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.

Authors:  H N Dawson; V Cantillana; M Jansen; H Wang; M P Vitek; D M Wilcock; J R Lynch; D T Laskowitz
Journal:  Neuroscience       Date:  2010-04-29       Impact factor: 3.590

Review 2.  A mitochondrial bottleneck hypothesis of Alzheimer's disease.

Authors:  J N Davis; E J Hunnicutt; J C Chisholm
Journal:  Mol Med Today       Date:  1995-08

3.  Mitochondrial modulation of store-operated Ca(2+) entry in model cells of Alzheimer's disease.

Authors:  Tuo Ma; Kai Gong; Yufang Yan; Bo Song; Xiufang Zhang; Yandao Gong
Journal:  Biochem Biophys Res Commun       Date:  2012-08-23       Impact factor: 3.575

4.  Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau.

Authors:  Rahul S Desikan; Linda K McEvoy; Wesley K Thompson; Dominic Holland; James B Brewer; Paul S Aisen; Reisa A Sperling; Anders M Dale
Journal:  Arch Neurol       Date:  2012-06

5.  Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.

Authors:  Erik D Roberson; Kimberly Scearce-Levie; Jorge J Palop; Fengrong Yan; Irene H Cheng; Tiffany Wu; Hilary Gerstein; Gui-Qiu Yu; Lennart Mucke
Journal:  Science       Date:  2007-05-04       Impact factor: 47.728

6.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

7.  Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease.

Authors:  Rodrigo A Quintanilla; Tori A Matthews-Roberson; Philip J Dolan; Gail V W Johnson
Journal:  J Biol Chem       Date:  2009-04-23       Impact factor: 5.157

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.

Authors:  Virginie Rhein; Xiaomin Song; Andreas Wiesner; Lars M Ittner; Ginette Baysang; Fides Meier; Laurence Ozmen; Horst Bluethmann; Stefan Dröse; Ulrich Brandt; Egemen Savaskan; Christian Czech; Jürgen Götz; Anne Eckert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

10.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

Authors:  H N Dawson; A Ferreira; M V Eyster; N Ghoshal; L I Binder; M P Vitek
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  10 in total

1.  Mechanisms of tau and Aβ-induced excitotoxicity.

Authors:  Susanne P Pallo; John DiMaio; Alexis Cook; Bradley Nilsson; Gail V W Johnson
Journal:  Brain Res       Date:  2015-12-28       Impact factor: 3.252

2.  Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.

Authors:  María José Pérez; Katiana Vergara-Pulgar; Claudia Jara; Fabian Cabezas-Opazo; Rodrigo A Quintanilla
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

Review 3.  Defective mitophagy and the etiopathogenesis of Alzheimer's disease.

Authors:  Kuan Zeng; Xuan Yu; Yacoubou Abdoul Razak Mahaman; Jian-Zhi Wang; Rong Liu; Yi Li; Xiaochuan Wang
Journal:  Transl Neurodegener       Date:  2022-06-03       Impact factor: 9.883

Review 4.  A Mitocentric View of Alzheimer's Disease.

Authors:  Hao Hu; Chen-Chen Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-10-01       Impact factor: 5.590

5.  Tortoise Plastron and Deer Antler Gelatin Prevents Against Neuronal Mitochondrial Dysfunction In Vitro: Implication for a Potential Therapy of Alzheimer's Disease.

Authors:  Dan Cheng; Xin-Jing Yang; Lu Zhang; Zong-Shi Qin; Wen-Qi Li; Hai-Chun Xu; Zhang-Jin Zhang
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 6.  Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration.

Authors:  María J Pérez; Claudia Jara; Rodrigo A Quintanilla
Journal:  Front Neurosci       Date:  2018-07-05       Impact factor: 4.677

Review 7.  The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.

Authors:  Rodrigo A Quntanilla; Carola Tapia-Monsalves
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

8.  Genetic ablation of tau improves mitochondrial function and cognitive abilities in the hippocampus.

Authors:  Claudia Jara; Alejandra Aránguiz; Waldo Cerpa; Cheril Tapia-Rojas; Rodrigo A Quintanilla
Journal:  Redox Biol       Date:  2018-07-19       Impact factor: 11.799

Review 9.  Much More Than a Cytoskeletal Protein: Physiological and Pathological Functions of the Non-microtubule Binding Region of Tau.

Authors:  Roland Brandt; Nataliya I Trushina; Lidia Bakota
Journal:  Front Neurol       Date:  2020-10-19       Impact factor: 4.003

10.  Cannabidiol Inhibits Tau Aggregation In Vitro.

Authors:  Soha Alali; Gholamhossein Riazi; Mohammad Reza Ashrafi-Kooshk; Sogol Meknatkhah; Shahin Ahmadian; Mohammad Hooshyari Ardakani; Baharak Hosseinkhani
Journal:  Cells       Date:  2021-12-13       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.